Page last updated: 2024-10-22

amitriptyline and Waldenstrom Macroglobulinemia

amitriptyline has been researched along with Waldenstrom Macroglobulinemia in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Waldenstrom Macroglobulinemia: A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tilz, GP1
Teubl, I1
Kopplhuber, C1
Vollmann, H1
Lanzer, G1

Other Studies

1 other study available for amitriptyline and Waldenstrom Macroglobulinemia

ArticleYear
[Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Medizinische Klinik, 1976, Nov-05, Volume: 71, Issue:45

    Topics: Adult; Amitriptyline; Antilymphocyte Serum; Bone Neoplasms; Female; Hemophilia A; Humans; Hyperthyro

1976